AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Sees Significant Increase in Short Interest

AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) was the recipient of a large growth in short interest in May. As of May 29th, there was short interest totaling 1,303,551 shares, a growth of 61.4% from the May 14th total of 807,696 shares. Currently, 5.1% of the shares of the stock are short sold. Based on an average trading volume of 583,155 shares, the short-interest ratio is presently 2.2 days.

Hedge Funds Weigh In On AGF U.S. Market Neutral Anti-Beta Fund

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Crescent Grove Advisors LLC acquired a new position in AGF U.S. Market Neutral Anti-Beta Fund in the 1st quarter valued at $6,614,000. Bank of New York Mellon Corp raised its holdings in AGF U.S. Market Neutral Anti-Beta Fund by 59.4% in the 1st quarter. Bank of New York Mellon Corp now owns 27,235 shares of the company’s stock valued at $380,000 after acquiring an additional 10,146 shares in the last quarter. Advisory Services Network LLC raised its holdings in AGF U.S. Market Neutral Anti-Beta Fund by 2,091.7% in the 4th quarter. Advisory Services Network LLC now owns 329,604 shares of the company’s stock valued at $4,743,000 after acquiring an additional 314,565 shares in the last quarter. J.Safra Asset Management Corp raised its holdings in AGF U.S. Market Neutral Anti-Beta Fund by 10.0% in the 4th quarter. J.Safra Asset Management Corp now owns 8,142 shares of the company’s stock valued at $117,000 after acquiring an additional 741 shares in the last quarter. Finally, Triumph Capital Management acquired a new position in AGF U.S. Market Neutral Anti-Beta Fund in the 3rd quarter valued at $70,000.

AGF U.S. Market Neutral Anti-Beta Fund Trading Up 0.4%

NYSEARCA BTAL traded up $0.04 during midday trading on Tuesday, hitting $11.21. The company had a trading volume of 28,612 shares, compared to its average volume of 864,393. The company has a market capitalization of $288.20 million, a PE ratio of 17.67 and a beta of -0.63. The firm has a 50-day moving average price of $12.32 and a 200-day moving average price of $13.52. AGF U.S. Market Neutral Anti-Beta Fund has a twelve month low of $11.13 and a twelve month high of $18.62.

About AGF U.S. Market Neutral Anti-Beta Fund

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.